title: Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.
abstract: A non-enzymatic reaction between reducing sugars and the amino groups of proteins, lipids and nucleic acids is known as the "Maillard reaction". The reactions have progressed in a normal aging process and at an accelerated rate under hyperglycemic, inflammatory, and/or oxidative stress conditions, thus leading to the formation and accumulation of advanced glycation end products (AGEs). Cross-linking modification of organic matrix proteins such as collagen by AGEs not only leads to an increase in vascular and myocardial stiffness, but also deteriorates structural integrity and physiological function of multiple organ systems. Furthermore, there is a growing body of evidence that interaction of AGEs with a cell surface receptor RAGE elicits oxidative stress generation and subsequently evokes inflammatory, thrombogenic and fibrotic reactions, thereby being involved in the development and progression of various age- or diabetes-related disorders, including cardiovascular disease (CVD), Alzheimer's disease, osteoporosis, cancer growth and metastasis. Skin AGE levels measured in biopsy specimens are associated with the development and progression of diabetic microangiopathy. Recently, accumulation levels of AGEs in the skin can be measured non-invasively by autofluorescence. Accumulating evidence has suggested that skin autofluorescence (SAF) is correlated with the presence and severity of vascular complications of diabetes and could predict future cardiovascular events and death in patients with diabetes. This review summarizes the pathophysiological role of tissue accumulation levels of AGEs in vascular damage in high-risk patients, especially focusing on the association between SAF and cardiorenal disorder.
authors: Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume 830-0011, Japan. Electronic address: shoichi@med.kurume-u.ac.jp.
authors: Sho-Ichi
authors: S
authors: Yamagishi
authors: Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
authors: Kei
authors: K
authors: Fukami
authors: Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume 830-0011, Japan.
authors: Takanori
authors: T
authors: Matsui
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000150:complications / Q000378:metabolism*; D003925:Diabetic Angiopathies / Q000150:complications / Q000378:metabolism*; D018450:Disease Progression; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D018384:Oxidative Stress; D012867:Skin / Q000378:metabolism* / Q000473:pathology
chemical_list: D015415:Biomarkers; D017127:Glycation End Products, Advanced
keywords: AGEs; Cardiovascular disease (CVD); Diabetes; RAGE; Skin autofluorescence (SAF)